HARBIN GLORIA PHARMACEUTICALS Co., LTD reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 593.13 million compared to CNY 681.17 million a year ago. Revenue was CNY 593.13 million compared to CNY 681.17 million a year ago.

Net income was CNY 52.28 million compared to CNY 20.06 million a year ago. Basic earnings per share from continuing operations was CNY 0.0235 compared to CNY 0.0091 a year ago. Diluted earnings per share from continuing operations was CNY 0.0235 compared to CNY 0.0091 a year ago.